{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T08:04:40Z","timestamp":1789545880259,"version":"build-2803163510"},"reference-count":42,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2011,4,1]],"date-time":"2011-04-01T00:00:00Z","timestamp":1301616000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,4,1]],"date-time":"2011-04-01T00:00:00Z","timestamp":1301616000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2011,4,1]],"date-time":"2011-04-01T00:00:00Z","timestamp":1301616000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2011,4,1]],"date-time":"2011-04-01T00:00:00Z","timestamp":1301616000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2011,4,1]],"date-time":"2011-04-01T00:00:00Z","timestamp":1301616000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2011,4,1]],"date-time":"2011-04-01T00:00:00Z","timestamp":1301616000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2011,4,1]],"date-time":"2011-04-01T00:00:00Z","timestamp":1301616000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100009940","name":"Lotto New Zealand","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009940","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001516","name":"National Heart Foundation of New Zealand","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001516","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001505","name":"Health Research Council of New Zealand","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001505","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jmmc-online.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Molecular and Cellular Cardiology"],"published-print":{"date-parts":[[2011,4]]},"DOI":"10.1016\/j.yjmcc.2011.01.010","type":"journal-article","created":{"date-parts":[[2011,1,28]],"date-time":"2011-01-28T04:18:29Z","timestamp":1296188309000},"page":"695-701","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":53,"title":["Association of genetic variation in the natriuretic peptide system with cardiovascular outcomes"],"prefix":"10.1016","volume":"50","author":[{"given":"Katrina L.","family":"Ellis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"Newton-Cheh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas J.","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chris M.","family":"Frampton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rob N.","family":"Doughty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gillian A.","family":"Whalley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chris J.","family":"Ellis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorraine","family":"Skelton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nick","family":"Davis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tim G.","family":"Yandle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard W.","family":"Troughton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. Mark","family":"Richards","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vicky A.","family":"Cameron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.yjmcc.2011.01.010_bb0005","first-page":"1791","article-title":"Hormones of the cardiovascular system","author":"Rademaker","year":"1999","journal-title":"Endocrinology"},{"key":"10.1016\/j.yjmcc.2011.01.010_bb0010","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1056\/NEJM199807303390507","article-title":"Natriuretic peptides","volume":"339","author":"Levin","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1016\/j.yjmcc.2011.01.010_bb0015","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1373\/clinchem.2003.024760","article-title":"Diagnostic accuracy and prognostic relevance of the measurement of cardiac natriuretic peptides: a review","volume":"50","author":"Clerico","year":"2004","journal-title":"Clin Chem"},{"key":"10.1016\/j.yjmcc.2011.01.010_bb0020","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/S0008-6363(01)00238-3","article-title":"The role of the natriuretic peptides in the cardiovascular system","volume":"51","author":"Suzuki","year":"2001","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.yjmcc.2011.01.010_bb0025","doi-asserted-by":"crossref","first-page":"1921","DOI":"10.1161\/01.CIR.97.19.1921","article-title":"Plasma N-terminal pro-brain natriuretic peptide and adrenomedullin: new neurohormonal predictors of left ventricular function and prognosis after myocardial infarction","volume":"97","author":"Richards","year":"1998","journal-title":"Circulation"},{"key":"10.1016\/j.yjmcc.2011.01.010_bb0030","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/S0140-6736(94)92690-5","article-title":"Plasma brain natriuretic peptide in assessment of acute dyspnoea","volume":"343","author":"Davis","year":"1994","journal-title":"Lancet"},{"key":"10.1016\/j.yjmcc.2011.01.010_bb0035","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1038\/ng.328","article-title":"Association of common variants in NPPA and NPPB with circulating natriuretic peptides and blood pressure","volume":"41","author":"Newton-Cheh","year":"2009","journal-title":"Nat Genet"},{"key":"10.1016\/j.yjmcc.2011.01.010_bb0040","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1038\/ng.361","article-title":"Genome-wide association study identifies eight loci associated with blood pressure","volume":"41","author":"Newton-Cheh","year":"2009","journal-title":"Nat Genet"},{"key":"10.1016\/j.yjmcc.2011.01.010_bb0045","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1097\/00005344-199801000-00017","article-title":"Combined neutral endopeptidase and angiotensin-converting enzyme inhibition in heart failure: role of natriuretic peptides and angiotensin II","volume":"31","author":"Rademaker","year":"1998","journal-title":"J Cardiovasc Pharmacol"},{"key":"10.1016\/j.yjmcc.2011.01.010_bb0050","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1046\/j.1365-2265.1997.2361058.x","article-title":"Immunoreactive amino-terminal pro-brain natriuretic peptide (NT-PROBNP): a new marker of cardiac impairment","volume":"47","author":"Hunt","year":"1997","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.yjmcc.2011.01.010_bb0055","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1210\/jcem-63-1-72","article-title":"Radioimmunoassay and characterization of atrial natriuretic peptide in human plasma","volume":"63","author":"Yandle","year":"1986","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.yjmcc.2011.01.010_bb0060","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1006\/bbrc.1999.0225","article-title":"The amino terminal regions of proBNP and proANP oligomerise through leucine zipper-like coiled-coil motifs","volume":"255","author":"Seidler","year":"1999","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.yjmcc.2011.01.010_bb0065","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/0196-9781(93)90102-M","article-title":"The ovine hypothalamus and pituitary have markedly different distribution of C-type natriuretic peptide forms","volume":"14","author":"Yandle","year":"1993","journal-title":"Peptides"},{"key":"10.1016\/j.yjmcc.2011.01.010_bb0070","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1042\/CS20030307","article-title":"N-terminal pro-C-type natriuretic peptide, but not C-type natriuretic peptide, is greatly elevated in the fetal circulation","volume":"106","author":"Prickett","year":"2004","journal-title":"Clin Sci (Lond)"},{"key":"10.1016\/j.yjmcc.2011.01.010_bb0075","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1006\/bbrc.2001.5419","article-title":"Identification of amino-terminal pro-C-type natriuretic peptide in human plasma","volume":"286","author":"Prickett","year":"2001","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.yjmcc.2011.01.010_bb0080","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/S0894-7317(89)80014-8","article-title":"Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-Dimensional Echocardiograms","volume":"2","author":"Schiller","year":"1989","journal-title":"J Am Soc Echocardiogr"},{"key":"10.1016\/j.yjmcc.2011.01.010_bb0085","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1016\/S0735-1097(02)02927-3","article-title":"Angiotensin-converting enzyme gene polymorphism interacts with left ventricular ejection fraction and brain natriuretic peptide levels to predict mortality after myocardial infarction","volume":"41","author":"Palmer","year":"2003","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.yjmcc.2011.01.010_bb0090","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1093\/bioinformatics\/bth457","article-title":"Haploview: analysis and visualization of LD and haplotype maps","volume":"21","author":"Barrett","year":"2005","journal-title":"Bioinformatics"},{"key":"10.1016\/j.yjmcc.2011.01.010_bb0095","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1007\/BF00220093","article-title":"Investigation of the polymorphic ScaI site by a PCR-based assay at the human atrial natriuretic peptides (hANP) gene locus","volume":"90","author":"Ramasawmy","year":"1992","journal-title":"Hum Genet"},{"key":"10.1016\/j.yjmcc.2011.01.010_bb0100","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1042\/cs0980251","article-title":"Genetic analysis of the atrial natriuretic peptide gene in essential hypertension","volume":"98","author":"Kato","year":"2000","journal-title":"Clin Sci (Lond)"},{"key":"10.1016\/j.yjmcc.2011.01.010_bb0105","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/j.jacc.2005.12.081","article-title":"Association of atrial natriuretic peptide and type a natriuretic peptide receptor gene polymorphisms with left ventricular mass in human essential hypertension","volume":"48","author":"Rubattu","year":"2006","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.yjmcc.2011.01.010_bb0110","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1067\/mhj.2003.52","article-title":"Association of the ScaI atrial natriuretic peptide gene polymorphism with nonfatal myocardial infarction and extent of coronary artery disease","volume":"145","author":"Gruchala","year":"2003","journal-title":"Am Heart J"},{"key":"10.1016\/j.yjmcc.2011.01.010_bb0115","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1161\/01.STR.0000119381.52589.AB","article-title":"Atrial natriuretic peptide gene polymorphisms and risk of ischemic stroke in humans","volume":"35","author":"Rubattu","year":"2004","journal-title":"Stroke"},{"key":"10.1016\/j.yjmcc.2011.01.010_bb0120","doi-asserted-by":"crossref","first-page":"1530","DOI":"10.1681\/ASN.V1071530","article-title":"Pronatriodilatin gene polymorphisms, microvascular permeability, and diabetic nephropathy in type 1 diabetes mellitus","volume":"10","author":"Nannipieri","year":"1999","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.yjmcc.2011.01.010_bb0125","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/j.bbrc.2007.08.028","article-title":"Linkage disequilibrium analyses of natriuretic peptide precursor B locus reveal risk haplotype conferring high plasma BNP levels","volume":"362","author":"Takeishi","year":"2007","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.yjmcc.2011.01.010_bb0130","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1093\/hmg\/ddm084","article-title":"Association between the T-381C polymorphism of the brain natriuretic peptide gene and risk of type 2 diabetes in human populations","volume":"16","author":"Meirhaeghe","year":"2007","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.yjmcc.2011.01.010_bb0135","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1291\/hypres.25.727","article-title":"A single-nucleotide polymorphism in C-type natriuretic peptide gene may be associated with hypertension","volume":"25","author":"Ono","year":"2002","journal-title":"Hypertens Res"},{"key":"10.1016\/j.yjmcc.2011.01.010_bb0140","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1161\/01.RES.86.8.841","article-title":"Functional deletion mutation of the 5\u2032-flanking region of type A human natriuretic peptide receptor gene and its association with essential hypertension and left ventricular hypertrophy in the Japanese","volume":"86","author":"Nakayama","year":"2000","journal-title":"Circ Res"},{"key":"10.1016\/j.yjmcc.2011.01.010_bb0145","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1291\/hypres.25.395","article-title":"A novel missense mutation of exon 3 in the type A human natriuretic peptide receptor gene: possible association with essential hypertension","volume":"25","author":"Nakayama","year":"2002","journal-title":"Hypertens Res"},{"key":"10.1016\/j.yjmcc.2011.01.010_bb0150","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1007\/s00439-002-0834-z","article-title":"Common variations in noncoding regions of the human natriuretic peptide receptor A gene have quantitative effects","volume":"112","author":"Knowles","year":"2003","journal-title":"Hum Genet"},{"key":"10.1016\/j.yjmcc.2011.01.010_bb0155","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1161\/01.RES.84.5.605","article-title":"Structure of the type B human natriuretic peptide receptor gene and association of a novel microsatellite polymorphism with essential hypertension","volume":"84","author":"Rehemudula","year":"1999","journal-title":"Circ Res"},{"key":"10.1016\/j.yjmcc.2011.01.010_bb0160","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1097\/00004872-199917090-00010","article-title":"A novel promoter variant of the natriuretic peptide clearance receptor gene is associated with lower atrial natriuretic peptide and higher blood pressure in obese hypertensives","volume":"17","author":"Sarzani","year":"1999","journal-title":"J Hypertens"},{"key":"10.1016\/j.yjmcc.2011.01.010_bb0165","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1291\/hypres.27.711","article-title":"Variable number of tandem repeat of the 5\u2032-flanking region of type-C human natriuretic peptide receptor gene influences blood pressure levels in obesity-associated hypertension","volume":"27","author":"Aoi","year":"2004","journal-title":"Hypertens Res"},{"key":"10.1016\/j.yjmcc.2011.01.010_bb0170","doi-asserted-by":"crossref","first-page":"H33","DOI":"10.1152\/ajpheart.2000.278.1.H33","article-title":"Effects of natriuretic peptides on load and myocardial function in normal and heart failure dogs","volume":"278","author":"Lainchbury","year":"2000","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.yjmcc.2011.01.010_bb0175","doi-asserted-by":"crossref","first-page":"1820","DOI":"10.1016\/S0735-1097(01)01233-5","article-title":"Intravenous atrial natriuretic peptide prevents left ventricular remodeling in patients with first anterior acute myocardial infarction","volume":"37","author":"Hayashi","year":"2001","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.yjmcc.2011.01.010_bb0180","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/j.jacc.2006.09.048","article-title":"Effects of intravenous atrial natriuretic peptide on cardiac sympathetic nerve activity and left ventricular remodeling in patients with first anterior acute myocardial infarction","volume":"49","author":"Kasama","year":"2007","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.yjmcc.2011.01.010_bb0185","first-page":"1108","article-title":"Effects of intravenous atrial natriuretic peptide on cardiac sympathetic nerve activity in patients with decompensated congestive heart failure","volume":"45","author":"Kasama","year":"2004","journal-title":"J Nucl Med"},{"key":"10.1016\/j.yjmcc.2011.01.010_bb0190","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1159\/000176909","article-title":"Cardiovascular function during brain natriuretic peptide infusion in man","volume":"86","author":"Lazzeri","year":"1995","journal-title":"Cardiology"},{"key":"10.1016\/j.yjmcc.2011.01.010_bb0195","doi-asserted-by":"crossref","first-page":"907","DOI":"10.2967\/jnumed.107.047548","article-title":"Prognostic value of serial cardiac 123I-MIBG imaging in patients with stabilized chronic heart failure and reduced left ventricular ejection fraction","volume":"49","author":"Kasama","year":"2008","journal-title":"J Nucl Med"},{"key":"10.1016\/j.yjmcc.2011.01.010_bb0200","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/S0002-9149(02)02595-X","article-title":"Usefulness of intravenous myocardial contrast echoardiography in the early left ventricular remodeling in acute myocardial infarction","volume":"90","author":"Mengozzi","year":"2002","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.yjmcc.2011.01.010_bb0205","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1136\/hrt.2007.122622","article-title":"Infarct size by contrast enhanced cardiac magnetic resonance is a stronger predictor of outcomes than left ventricular ejection fraction or end-systolic volume index: prospective cohort study","volume":"94","author":"Wu","year":"2008","journal-title":"Heart"},{"key":"10.1016\/j.yjmcc.2011.01.010_bb0210","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1007\/s00259-009-1084-2","article-title":"Prognostic significance of stress myocardial gated SPECT among Japanese patients referred for coronary angiography: a study of data from the J-ACCESS database","volume":"36","author":"Momose","year":"2009","journal-title":"Eur J Nucl Med Mol Imaging"}],"container-title":["Journal of Molecular and Cellular Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022282811000319?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022282811000319?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,19]],"date-time":"2025-09-19T20:20:59Z","timestamp":1758313259000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022282811000319"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,4]]},"references-count":42,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2011,4]]}},"alternative-id":["S0022282811000319"],"URL":"https:\/\/doi.org\/10.1016\/j.yjmcc.2011.01.010","relation":{},"ISSN":["0022-2828"],"issn-type":[{"value":"0022-2828","type":"print"}],"subject":[],"published":{"date-parts":[[2011,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Association of genetic variation in the natriuretic peptide system with cardiovascular outcomes","name":"articletitle","label":"Article Title"},{"value":"Journal of Molecular and Cellular Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.yjmcc.2011.01.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2011 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}